Table 2.
Substance | All patients (N = 1044) | Mean dosage [mg] |
---|---|---|
Quetiapine | 24.1% (252) | 272.4 ± 208.7 |
Lorazepam | 18.1% (189) | 2.2 ± 1.8 |
Mirtazapine | 15.0% (157) | 30.5 ± 14.9 |
Venlafaxine | 12.7% (133) | 185.0 ± 79.7 |
Sertraline | 11.1% (116) | 99.1 ± 49.6 |
Olanzapine | 10.0% (104) | 11.0 ± 7.1 |
Escitalopram | 8.1% (85) | 15.0 ± 6.7 |
Trazodone | 6.8% (71) | 149.3 ± 77.9 |
Citalopram | 6.7% (70) | 29.8 ± 13.0 |
Duloxetine | 6.3% (66) | 85.9 ± 34.6 |
Risperidone | 5.8% (61) | 2.5 ± 1.5 |
Chlorprothixene | 5.6% (59) | 107.7 ± 151.1 |
Trimipramine | 5.7% (60) | 93.6 ± 83.3 |
Pregabalin | 5.2% (54) | 270.0 ± 182.5 |
… | … | … |
Paroxetine | 3.7% (39) | 32.3 ± 15.8 |
Further included is paroxetine (approved in Germany, Austria and Switzerland)